On a year on year (YoY) basis, Tech Mahindra's net profit dropped 40.86% while revenue fell 6.17% in Q4 FY24.

EBITDA stood at Rs 1,407.8 crore in the quarter ended 31 March 2024, up 22.8% QoQ and down 30.3% YoY. EBITDA margin was at 10.9% in Q4 FY24 as compared to 8.8% in Q3 FY24 and 14.7% in Q4 FY23.

In terms of dollars (USD), revenue stood at $1,548.2 million in Q4 FY24, registering a de-growth of 1.6% QoQ and 7.2% YoY. In constant currency terms, revenue declined by 0.8% QoQ and down 6.4% YoY. Profit after tax was at $79.7 million, up 29.5% QoQ and down 41.5% YoY. Free cash flow was at $129 million in the March quarter.

During the quarter, EBITDA was at $169.2 million, up 22.9% QoQ and down 31.1% YoY. EBITDA margin came in at 10.9% in Q4 FY24, up 220 bps QoQ.

The IT firm secured net new deals worth $500 million in Q4 FY24 as against $381 million in Q3 FY24 and $592 million reported in Q4 FY23.

Total headcount was at 145,455, registering a decline of 1% QoQ and 4.6% YoY. The last twelve month (LTM) IT attrition rate was constant at 10% in Q4 FY24 as compared to Q3 FY24, while in Q4 FY23 attrition rate was 15%.

On full year basis, the company?s consolidated net profit tumbled 51.2% to Rs 2357.8 crore on 2.43% decline in revenue to Rs 51,995.5 crore in FY24 over FY23.

Cash and cash equivalent was at Rs 7,911.5 crore as of 31 March 2024, compared with Rs 7,012.3 crore as of 31 December 2023 and Rs 7,435.1 crore as of 31 March 2023.

Rohit Anand, CFO of Tech Mahindra said, ?With another quarter of robust cash generation, we have reported improvement in deal wins and operating margins in Q4FY'24, which has enabled consistent dividend distribution. We are confident that our actions will lead to steady earnings growth in the coming years. We will continue to focus on operational excellence and cost savings to deliver superior shareholder returns.?

Meanwhile, the company?s board has recommended a final dividend of Rs 28 per equity share for FY24. The dividend, if approved, will be paid on or before, 9 August 2024.

Tech Mahindra is focused on leveraging next-generation technologies including 5G, blockchain, cybersecurity, artificial intelligence, and more, to enable end-to-end digital transformation for global customers.

Shares of Tech Mahindra added 0.34% to end at Rs 1,190.10 on the BSE.

Profit before tax fell 27.1% YoY to Rs 107.27 crore in Q4 FY24.

EBITDA fell 10% to Rs 259 crore in Q4 FY24 from Rs 287 crore posted in Q4 FY23.EBITDA margin reduced by 280 bps to 18% in Q4 FY24 as against 20.8% in Q4 FY23.

Research and development (R&D) spends reported at Rs 69 crore and around 4.8% of revenues; Higher spends over last year partly due to additional spend towards CGT space.

The pharma company?s formulation business grew 9% to Rs 430 crore in the quarter ended 31 March 2024 as compared with Rs 393 crore in the quarter ended 31 March 2023.

Income from API business jumped 4% YoY to Rs 745 crore, supported from growth across franchise despite continuing pricing pressure in other APIs segment. As on 31 March 2024, the company has filed 342 patents out of that 228 patents granted. Cumulative DMFs filings stood at 83.

In Q4 FY24, CDMO-Synthesis business reported revenue of Rs 236 crore, up 4% YoY. Bio-transformation & Continuous Flow platform witnessed strong customer interest driven by rising complexity, faster time to market further fueled by increasing sustainability pressure.

Revenue from Laurus Bio division tumbled 37% YoY to Rs 29 crore, mainly transitionary in nature due to customer order cyclicality.

Meanwhile, the company?s board has declared a dividend of Rs 0.40 per share of face value of Rs 2 each for financial year 2023-2024. It has fixed 8 May 2024 as record date for determining the eligibility of the shareholders. The dividend amount will be paid on or after 17 May 2024.

Satyanarayana Chava , founder and chief executive officer, said, ?Laurus core results reflects continued resilience across our business divisions despite discontinuation of Covid related products purchase orders. We delivered underlying revenue growth of 9% driven by strong performance in FDF, CDMO, Onco API and Bio division.

In the CDMO space, we are delivering on multiple RFPs involving higher chemical complexity and scale with increased customer engagement focusing on several sustainable technology platforms. Our on-going innovative CGT investment continue to report significant updates for the period under review, especially successful NexCAR19 commercial launch in India to treat cancers

We are entering FY25 with solid foundation and remain committed to grow by focusing on R&D led commercial excellence. We are prioritizing efforts to improve margin, particularly increasing asset utilization across network and delivering late phase commercial opportunity.?

V.V. Ravi Kumar, executive director & chief financial officer, said, ?Overall FY24 reported operating result was challenging driven by selling price decline in ARV products, absence of large PO, and continued OPEX on growth projects/new initiatives. We achieved Rs 5,041 crore in revenues, representing 17% decline. Excluding the large PO the underlying growth was 9% over last year.

Gross margin was 51.7% and EBITDA at Rs 798 crore resulting in 15.8% margin. The EBIDTA margin for the Q4FY24 is at 18.0% and reflecting sequential improvement. Despite operational challenges, our committed capacity built-up is on track and continuing our focus on productivity improvement. Going ahead, we are fully focusing on gradually returning to growth, prioritising investments in high value segments, improving Net debt leverage while defining our strategic roadmap to ensure long-term profitable and sustainable growth.?

Laurus Labs is a fully integrated pharmaceutical and biotechnology company, with a leadership position in generic active pharmaceutical ingredients (APIs) and a major focus on anti-retroviral, oncology drugs, cardiovascular, gastro and hepatitis C therapeutics. The company also develops and manufactures oral solid formulations, provide contract research and manufacturing services (CRAMS) to global pharma companies.

Clinker & cement sales volume increased by 23.5% YoY at 10.4 million tonne during the March 2024 quarter. Ready mix concrete registered a decline of 7.04% YoY in volume to 0.66 million cubic meters, during the period under review.

Profit before tax in fourth quarter of FY24 soared 167.10% to Rs 885.04 crore from Rs 331.35 crore recorded in corresponding quarter previous year.

In Q4 FY24, operating EBITDA increased 78.46% to Rs 837 crore from Rs 469 crore posted in same quarter last year while EBITDA margin improved to 15.5% from 9.8% posted in Q4 FY23.

On outlook front, the cement maker said that cement industry remains positive based on higher budgetary allocation to infrastructure and construction and government?s push for affordable housing along with green energy transition, demand-supply dynamics, and greater consolidation. Adani Cement will have the advantage of accelerated growth, lower cost, group synergies which in turn will help to sustainable performance & market leadership.

On a full year basis, the company?s net profit soared by 163.98% to Rs 2,336.37 crore in FY24 over FY23. However, revenue from operation declined 10.14% YoY to Rs 19,958.92 crore in the financial year ended 31 March 2024.

Ajay Kapur, whole time director & CEO, said, ?We continue to solidify our position as a frontrunner in the cement industry. Our financial performance with jump in EBITDA by 138% during the year is a testament to the flexibility and strong foundation of our business model. The trust of our customers and our commitment to building a sustainable future with investment in efficiency improvements, green power etc. has furthered our success, as we emerge even stronger than before. With passing time ACC is getting younger and stronger with the expansion and performance efficiency plans.?

Cash & cash equivalent stood at Rs 4,667 crore and consolidated net worth improved by Rs 2,191 crore to reach Rs 16,333 crore as on 31 March 2024.

Meanwhile, the board has recommended a dividend of Rs 7.50 per equity share for the financial year 2023-24, subject to approval of shareholders. The company has fixed 14 June 2024 as ?record date? for the said dividend and it shall be paid on or after 1 July 2024.

ACC is a part of Adani Cement and one of India's leading producers of cement and ready-mix concrete. ACC has 16 cement manufacturing sites, over 85 concrete plants and a nationwide network of channel partners to serve its customers.

The scrip settled 0.85% higher at Rs 2,579.70 on the BSE.

The miner reported revenue of Rs 34,937 crore in March 2024 quarter, registering a de-growth of 6.15% YoY.

EBITDA de-grew 4% YoY to Rs 8,969 crore while EBITDA margin in Q4 FY24 improved to 30% as against 29% posted in Q4 FY23.

Depreciation & amortisation for Q4 FY24 declined by 1% YoY to Rs 2,743 crore, mainly in oil and gas partially offset by increased ore production at Zinc India.

Investment Income for fourth quarter of FY24 slipped by 43% to Rs 543 crore as compared to Rs 958 crore posted in Q4 FY23.

The company's gross debt stood at Rs 71,759 crore while net debt was Rs 56,338 crore on 31 March 2024.

Cash and cash equivalents position remained healthy at Rs 15,421 crore. The company follows a board-approved investment policy and invests in high quality debt instruments with mutual funds, bonds, and fixed deposits with banks.

For financial year 2024, the diversified metals company reported 59.91% decline in consolidated net profit to Rs 4,239 crore on 2.48% fall in revenue from operations to 1,41,793 crore over FY23.

Arun Misra, executive director of Vedanta, said ?FY 2023-24 has been a remarkable year for Vedanta. We have achieved record production across our key businesses, a testament to our consistent focus on operational excellence. This focus, coupled with our commitment to cost leadership, ensured strong margins even during a challenging commodity market. HZL is now the world's 3rd largest silver producer.

This focus is further strengthened by securing 1,826 MW of renewable power through PDAs, with the first power delivery scheduled for Q1 FY25. As we move forward, operational excellence, continued growth, and ESG leadership remains our strategic priorities.?

Ajay Goel, chief financial officer (CFO) of Vedanta, said ?Driven by operational excellence, Vedanta achieved outstanding financial results, marking the second highest annual revenue and EBITDA in our history, reaching Rs 1,41,793 crore and Rs 36,455 crore respectively. Through continued cost optimization, we achieved a remarkable EBITDA margin of 30% in FY24 with 240 basis points annual margin expansion, underscoring our efficiency and agility.

Moreover, our net debt/EBITDA ratio improved to 1.5x from 1.7x in December 2023. At Holdco, we deleveraged by $1.6bn in FY24 & through successful liabilities management, Vedanta has a balanced capital structure, and will remain committed towards value creation.?

Vedanta, a subsidiary of Vedanta Resources, is one of the world's leading oil & gas and metals company with significant operations in oil & gas, zinc, lead, silver, copper, iron ore, steel, and aluminium & power across India, South Africa and Namibia.

The scrip closed 0.64% lower at Rs 380.80 on the BSE.

The bonus shares will be issued out of securities premium account of the company. As on 31 March 2023, aggregate amount of free reserves and securities premium account available for capitalization is Rs 1995.18 crore.

Inox Wind is a wind energy solutions provider in India, catering to IPPs, Utilities, PSUs, and Corporate investors. It is part of the INOXGFL Group, with a focus on chemicals and renewable energy. IWL is fully integrated in the wind energy market, with four manufacturing plants and a capacity of over 2 GW per annum.

On a consolidated basis, Inox Wind reported consolidated net profit to Rs 1.07 crore in Q3 FY24 as against net loss of Rs 287.22 crore in Q3 FY23. Net sales jumped 122.6% YoY to Rs 503.45 crore in Q4 FY24.

The scrip hit all time high of Rs 658.50 in today?s intraday session.

Profit before tax declined 34.39% to Rs 129.67 crore in the quarter ended 31 March 2024 as compared with Rs 197.63 crore in the quarter ended 31 March 2023.

EBITDA stood at Rs 144.6 crore in Q4 FY24, registering the de-growth of 30.91% as compared with Rs 209.3 crore posted in corresponding quarter last year. In Q4 FY24, EBITDA margin reduced to 26.9% as against 33.7% in Q4 FY23.

During the quarter, Generic API Business fell 8.6% YoY to Rs 484.6 crore was impacted due to the Red Sea Crisis in external business and de-growth in GPL?s business.

CDMO business declined 37.7% to Rs 35.4 crore in Q4 FY24 as compared with Rs 56.8 crore in Q4 FY23.

Revenue from GPL business in Q4 FY24 dropped by 27.8% to Rs 166.7 crore as compared with Rs 230.9 crore in Q4 FY23. GPL business contributes 31% of the total revenue from operations. External business saw de-growth of 5.2% YoY on account of delay of shipments due to Red Sea crisis.

Regulated market witnessed 83% growth was driven by YoY growth in Europe and LATAM.

On Financial year 2024 basis, the company reported net profit marginally higher to Rs 470.9 crore in FY24 as compared with Rs 467 crore in FY23. Revenue from operations increased 5.6% YoY to Rs 2,283.2 crore in FY24.

During FY24, company generated strong free cash flow of Rs 284.5 crore leading to cash and cash equivalents of Rs 301.4 crore as of 31 March 2024.

Yasir Rawjee, MD & CEO, Glenmark Life Sciences, said, ?FY24 was a milestone year for Glenmark Life Sciences, marked by the successful acquisition by Nirma. With Nirma's commitment and strategic vision, we are poised for accelerated growth and market positioning. We concluded the financial year on a positive note with revenue growth of 5.6% on full year basis, driven by regulated markets in external business. Our commitment to high-quality, innovative solutions and scalability will fuel sustainable long-term growth. These, coupled with a strong order book and demand visibility will ensure steady growth in FY25 and beyond.?

Tushar Mistry, CFO, Glenmark Life Sciences, said, ?Despite global uncertainties and our integration efforts with Nirma, we achieved a revenue growth of 5.6% in FY24. Our annualized margins continue to be in the range of around 30% despite one-time costs such as bonuses and transaction expenses. Our strong free cash flow generation in FY24 has bolstered our financial standing, enabling continued growth while maintaining a debt-free balance sheet.?

In Q4FY24, 6 new products were added to the development grid, of which 4 products are High potent API (HP API) / Oncology class of drugs and 2 are synthetic small molecules. According to IQVIA MAT December 2023, the HP API portfolio now extends to 17 products with an addressable market of $37 billion. 3 products are validated, and 4 products are in advanced stage of development.

Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals, is a developer and manufacturer of select high-value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes.

Dalmia Bharat Ltd, Bharat Bijlee Ltd, Indian Hotels Co Ltd and Aster DM Healthcare Ltd are among the other losers in the BSE's 'A' group today, 25 April 2024.

Kotak Mahindra Bank Ltd lost 11.25% to Rs 1635.7 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 23.71 lakh shares were traded on the counter so far as against the average daily volumes of 1.97 lakh shares in the past one month.

Dalmia Bharat Ltd tumbled 8.13% to Rs 1800. The stock was the second biggest loser in 'A' group.On the BSE, 1.18 lakh shares were traded on the counter so far as against the average daily volumes of 12639 shares in the past one month.

Bharat Bijlee Ltd crashed 5.78% to Rs 3126.5. The stock was the third biggest loser in 'A' group.On the BSE, 4800 shares were traded on the counter so far as against the average daily volumes of 3303 shares in the past one month.

Indian Hotels Co Ltd corrected 5.10% to Rs 577.2. The stock was the fourth biggest loser in 'A' group.On the BSE, 3.93 lakh shares were traded on the counter so far as against the average daily volumes of 1.22 lakh shares in the past one month.

Aster DM Healthcare Ltd shed 3.80% to Rs 368.7. The stock was the fifth biggest loser in 'A' group.On the BSE, 99661 shares were traded on the counter so far as against the average daily volumes of 31.61 lakh shares in the past one month.

All three subsidiaries were incorporated on 24 April 2024, under the Companies Act, 2013, and are registered in the State of Rajasthan. Their primary focus will be on the development of solar power projects.

H G Infra Engineering is primarily involved in the construction of roads and highways in Odisha, Telangana, Rajasthan, Delhi, Andhra Pradesh, Haryana, and Uttar Pradesh. HGIEL is accredited AA class by the Public Works Department (PWD) of the Government of Rajasthan (GoR) and is registered as an SS class contractor by the Military Engineer Services (MES).

The company?s consolidated net profit decreased 22.03% to Rs 102.05 crore despite of 15.15% increase in revenue from operations to Rs 1,364.53 crore in Q3 FY24 over Q3 FY23.

Moschip Technologies Ltd, Weizmann Ltd, 5Paisa Capital Ltd and Archidply Decor Ltd are among the other losers in the BSE's 'B' group today, 25 April 2024.

Avantel Ltd tumbled 14.25% to Rs 109.5 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 28.5 lakh shares were traded on the counter so far as against the average daily volumes of 7.65 lakh shares in the past one month.

Moschip Technologies Ltd crashed 7.12% to Rs 156.2. The stock was the second biggest loser in 'B' group.On the BSE, 42.95 lakh shares were traded on the counter so far as against the average daily volumes of 31.42 lakh shares in the past one month.

Weizmann Ltd lost 6.36% to Rs 133.25. The stock was the third biggest loser in 'B' group.On the BSE, 22203 shares were traded on the counter so far as against the average daily volumes of 21609 shares in the past one month.

5Paisa Capital Ltd fell 6.26% to Rs 538.75. The stock was the fourth biggest loser in 'B' group.On the BSE, 48018 shares were traded on the counter so far as against the average daily volumes of 22410 shares in the past one month.

Archidply Decor Ltd pared 5.00% to Rs 83. The stock was the fifth biggest loser in 'B' group.On the BSE, 1079 shares were traded on the counter so far as against the average daily volumes of 6916 shares in the past one month.

Pre-tax loss for fourth quarter of FY24 increased to Rs 309.34 crore from Rs 277.07 crore recorded in corresponding quarter previous year.

EBITDA grew 8.19% to Rs 142.45 crore during the quarter as against Rs 131.67 crore posted in Q4 FY23.

On a full year basis, the company?s net loss increased to Rs 1,228.44 crore in FY24 as against Rs 1,144.72 crore posted in FY23. Revenue from operations rose 7.72% to Rs 1,191.65 crore in the financial year ended 31 March 2024.

Tata Teleservices (Maharashtra) is a leading player in the connectivity and communication solutions market for SMEs. With services ranging from Connectivity, Collaboration, Cloud & SaaS, Security, and Marketing solutions, we offer a comprehensive portfolio of Information and Communication Technology (ICT) solutions for businesses in India under the brand name Tata Tele Business Services (TTBS).

Pre-provisioning profit in Q4 FY24 was at Rs 571 crore, registering a growth of 16%YoY. Provisions soared 387.06% YoY to Rs 158.93 crore in Q3 FY24.

The bank's total deposits increased 26% YoY to Rs 87,182 crore. CASA deposits increased by 9% YoY to Rs 29,126 crore compared to Rs 26,660 crore in Q4 FY23; CASA ratio was at 33% and CASA and Retail deposits stood at 64%.

In Q4 FY24, gross advances increased by 25% YoY to Rs 73,999 crore. Of the total advances, Vehicle Loan contributes 30% and Micro Business Loans (MBL), Home Loan as well as Commercial Banking Loans contribute 28%, 8% and 25% respectively. Cost of funds stood at 7% in Q4 FY24 as against 6.3% in Q4 FY23.

On the asset quality front, the bank's gross non-performing assets (NPAs) stood at Rs 1,237.40.crore as on 31 March 2024 as against Rs 981.31 crore as on 31 March 2023.

The ratio of gross NPAs to gross advances was at 1.67% as on 31 March 2024 as compared to 1.66% as on 31 March 2023. The ratio of net NPA to net advances stood at 0.55% as on 31 March 2024 as against 0.42% as on 31 March 2023.

Provisioning coverage ratio (PCR) remained stable at 76%. Bank is carrying provisions of Rs 111 crore towards standard restructured book and floating provisioning

Post receiving RBI approval on March 4, 2024, the merger of Fincare SFB with and into AU SFB became effective from April 1, 2024, and Some key numbers on a proforma merged basis as on 31st March 2024, Deposits of profoma merged stood at Rs 97,704 crore Gross loan portfolio was Rs 96,460 crore and cost of fund on merged basis stood at 7.1%.

Meanwhile, the company?s board has declared a dividend of Rs 1 per share out of net profit for the financial year ended March 31, 2024.

Sanjay Agarwal, Founder, MD & CEO, of AU Small Finance Bank, said, ?Our performance in the current quarter has remained absolutely on track with deposit growth outpacing advances growth, margins broadly remaining within our guided range and asset quality continuing to be robust.

I am happy that our merger with Fincare has received all regulatory approvals in record time, and we are now operating as a merged entity. We now have 2,383 physical touchpoints across India and apart from a brick-and-mortar presence, we have a body and soul present in all these locations, giving us an extensive network which ensures we're closer to our customers than ever before and fast forwards our distribution build-out by many years.?

AU Small Finance Bank (AU SFB/AU) is a scheduled commercial bank, a Fortune India 500 Company and the largest Small Finance Bank in the country.

Jupiter Wagons Ltd, Kotak Mahindra Bank Ltd, Jyothy Labs Ltd, Godfrey Phillips India Ltd are among the other stocks to see a surge in volumes on NSE today, 25 April 2024.

Sun Pharma Advanced Research Company Ltd witnessed volume of 142.26 lakh shares by 14:14 IST on NSE, a 154.41 times surge over two-week average daily volume of 92131 shares. The stock dropped 5.00% to Rs.270.90. Volumes stood at 2.17 lakh shares in the last session.

Jupiter Wagons Ltd registered volume of 131.07 lakh shares by 14:14 IST on NSE, a 14.21 fold spurt over two-week average daily volume of 9.22 lakh shares. The stock rose 7.82% to Rs.422.00. Volumes stood at 5.19 lakh shares in the last session.

Kotak Mahindra Bank Ltd recorded volume of 545.88 lakh shares by 14:14 IST on NSE, a 12.16 times surge over two-week average daily volume of 44.88 lakh shares. The stock lost 11.06% to Rs.1,639.05. Volumes stood at 32.95 lakh shares in the last session.

Jyothy Labs Ltd clocked volume of 36.73 lakh shares by 14:14 IST on NSE, a 7.68 times surge over two-week average daily volume of 4.78 lakh shares. The stock gained 2.51% to Rs.432.20. Volumes stood at 4.52 lakh shares in the last session.

Godfrey Phillips India Ltd clocked volume of 4.91 lakh shares by 14:14 IST on NSE, a 7.13 times surge over two-week average daily volume of 68868 shares. The stock gained 9.47% to Rs.3,427.60. Volumes stood at 22605 shares in the last session.

Among the components of the S&P BSE Consumer Discretionary index, Indian Hotels Co Ltd (down 5.1%), Macrotech Developers Ltd (down 4.15%),KDDL Ltd (down 2.99%),Amara Raja Energy & Mobility Ltd (down 2.9%),Federal-Mogul Goetze (India) Ltd (down 2.83%), were the top losers. Among the other losers were Avenue Supermarts Ltd (down 2.57%), Whirlpool of India Ltd (down 2.04%), Sai Silks (Kalamandir) Ltd (down 1.95%), Landmark Cars Ltd (down 1.93%), and Shankara Building Products Ltd (down 1.9%).

On the other hand, Faze Three Ltd (up 8.55%), Saint-Gobain Sekurit India Ltd (up 7.98%), and New Delhi Television Ltd (up 7.81%) moved up.

At 13:42 IST, the S&P BSE Sensex was up 214.31 or 0.29% at 74067.25.

The Nifty 50 index was up 58.6 points or 0.26% at 22461.

The S&P BSE Small-Cap index was up 260.52 points or 0.56% at 47119.12.

The S&P BSE 150 Midcap Index index was up 51.86 points or 0.37% at 13949.38.

On BSE,2087 shares were trading in green, 1646 were trading in red and 132 were unchanged.

Among the components of the S&P BSE Consumer Durables index, Whirlpool of India Ltd (up 2.04%), Dixon Technologies (India) Ltd (up 1.32%), Titan Company Ltd (up 1.19%), Crompton Greaves Consumer Electricals Ltd (up 0.9%), Havells India Ltd (up 0.63%), and V I P Industries Ltd (up 0.06%), were the top losers.

On the other hand, Aditya Birla Fashion & Retail Ltd (up 2.08%), Rajesh Exports Ltd (up 0.8%), and Blue Star Ltd (up 0.79%) moved up.

At 13:42 IST, the S&P BSE Sensex was up 214.31 or 0.29% at 74067.25.

The Nifty 50 index was up 58.6 points or 0.26% at 22461.

The S&P BSE Small-Cap index was up 260.52 points or 0.56% at 47119.12.

The S&P BSE 150 Midcap Index index was up 51.86 points or 0.37% at 13949.38.

On BSE,2087 shares were trading in green, 1646 were trading in red and 132 were unchanged.

Among the components of the S&P BSE Realty Index index, Macrotech Developers Ltd (down 4.15%), Phoenix Mills Ltd (down 1.17%),Oberoi Realty Ltd (down 1.16%),DLF Ltd (down 0.98%),Mahindra Lifespace Developers Ltd (down 0.77%), were the top losers. Among the other losers were Prestige Estates Projects Ltd (down 0.75%), and Godrej Properties Ltd (down 0.31%).

On the other hand, Brigade Enterprises Ltd (up 1.61%), Sobha Ltd (up 0.76%), and Swan Energy Ltd (up 0.31%) turned up.

At 13:42 IST, the S&P BSE Sensex was up 214.31 or 0.29% at 74067.25.

The Nifty 50 index was up 58.6 points or 0.26% at 22461.

The S&P BSE Small-Cap index was up 260.52 points or 0.56% at 47119.12.

The S&P BSE 150 Midcap Index index was up 51.86 points or 0.37% at 13949.38.

On BSE,2087 shares were trading in green, 1646 were trading in red and 132 were unchanged.

Revenue from operations increased by 36% YoY to Rs 489.96 crore during the quarter.

Total expenses rose by 27% to Rs 406.81 crore in the fourth quarter as compared with the same period last year, due to higher raw material costs (up 63% YoY) and higher other expenses (up 9% YoY).

Profit before tax in Q4 FY24 stood at Rs 80.72 crore, up by 92% from Rs 42.05 crore in Q4 FY24.

For the financial year 2023-24, Kirloskar Pneumatic has recorded net profit and revenue of Rs 133.28 crore (up 23% YoY) and Rs 1,322.62 crore (up 7% YoY), respectively.

Kirloskar Pneumatic Company has three divisions: air compressors, refrigeration and gas compressors, and transmission products. Manufacturing facilities of all divisions are integrated and are in and around Pune. End users include the oil and gas, steel, power, railways and defence sectors.

Revenue from operations rose 9.05% year on year to Rs 5267.59 crore in the quarter ended 31 March 2023.

The company had earlier informed the exchanges about changing the financial year from ?1st January - 31st December? cycle to ?1st April - 31st March? cycle. Accordingly, the current financial year of the company stands extended up to 31 March 2024, covering a period of 15 months commencing from 1 January 2023 to 31 March 2024, comprising five quarters.

Total sales increased by 9.28% YoY to Rs 5,254.43 crore in the January-March 2024 period. During the quarter, domestic sales grew by 8.86% and export sales rose 15.96%.

Profit before exceptional items and tax was at Rs 1,240.50 crore in the March quarter, up 25.24% from Rs 990.46 crore posted in January-March quarter 2024.

The company recognized an exceptional item of Rs 10.08 crore for the quarter ended 31 March 2024. This partially reverses a one-time expense of Rs 107.30 crore recorded in the December 2023 quarter due to changes in the cost of servicing the company's pension plan. This reversal reflects the transfer of responsibility for making monthly pension payments to an insurance service provider.

Suresh Narayanan, chairman and managing director of Nestl? India, said, ?I am pleased to share that we have delivered double-digit growth, despite challenges posed by rising food inflation and volatile commodity prices. We have witnessed a strong growth momentum across our product portfolio led by a combination of pricing and mix. Our domestic sales crossed Rs 5,000 crore this quarter.

In the financial year ended 31 March 2024, confectionery delivered strong performance, fuelled by KITKAT, making India the second-largest market for the brand globally. Our Beverages business recorded robust performance. NESCAF? has introduced its coffee to over 30 million households in India in the last 7 years. Milk Products and Nutrition witnessed strong growth despite inflationary pressures. Prepared dishes and cooking aids registered strong growth across portfolio led by MAGGI Noodles and MAGGI Masala-ae-Magic. India emerged as the largest market worldwide for MAGGI.

The Out-of-Home business reported strong growth and e-commerce sustained its upward trajectory, contributing to 6.8 % of sales. We remained steadfast on our RUrban journey and expanded to encompass over 200,000 villages, marking a significant milestone in our journey.

The pursuit of new platforms and categories is a key component of Nestl? India's overall growth strategy and reflects our commitment to anticipating and responding to evolving market trends and consumer preferences.?

Meanwhile, Nestle India?s board has approved the execution of a definitive agreement to form a joint venture between the company and Dr. Reddy?s Laboratories to bring together the well-known global range of nutritional health solutions as well as vitamins, minerals and health supplements of Nestl? Health Science with the nutraceuticals portfolios, strong and established commercial strengths of Dr. Reddy?s in India and other geographies. The joint venture is expected to become operational in the second quarter of the financial year 2024-25, subject to customary closing conditions.

The joint venture company would be formed with Dr Reddy?s holding 51% and Nestl? India?s holding 49%. Nestl? India will have a call option to increase shareholding upto 60% after six years at a fair market value. Dr Reddy?s shall continue to hold at least 40% of the shareholding after the company exercises its call option, it added.

On its commodity outlook, the company stated, ?Commodity prices are seeing unprecedented headwinds in coffee and cocoa with all time high prices and an ongoing price rally. Cereals and grains are going through a structural cost increase backed by MSP. Milk prices expected to rise on account of expected harsh summer.?

Further, the firm's board has recommended a final dividend of Rs 8.50 per equity share for FY2024. The record has been fixed on 15 July 2024.

Nestl? is the world's largest food and beverage company. It manufactures internationally famous brand names such as Nescaf?, Maggi, Milkybar, Kit Kat, Bar-One, Milkmaid and Nestea.

Profit before tax in fourth quarter of FY24 slumped 60.39% to Rs 7.61 crore from Rs 19.21 crore recorded in corresponding quarter previous year.

For Q4 FY24, EBITDA tumbled 52.53% to Rs 10.3 crore as against 21.70 crore reported in Q4 FY23. EBITDA margin dropped to 9% in Q4 FY24 from 24% in same quarter last year.

On a full year basis, the company?s net profit increased by 24.95% to Rs 54.44 crore in FY24 over FY23. Revenue from operation rose 16.79% to Rs 394.57 crore in the financial year ended 31 March 2024.

Narayan Gangadhar, CEO, commented: ?In Q4 FY24, at an industry level, we saw an addition of more than 1.2 crore demat accounts taking the total demat accounts in the country to 15.13 crore. During the same period, we acquired 2.67 lakh customers, reflecting a 15% growth QoQ (96% growth YoY), and with this our total customer base reached 42.3 lakhs. We are also happy to report that we have posted our highest quarterly revenue since inception in Q4FY24 of Rs 112.9 crore, up 13% QoQ (up 24% YoY).

During the past quarter, our total average daily turnover grew to Rs 3.82 trillion (up 58% YoY), our average client funding book stood at Rs 358 crore, up 13% QoQ and the number of orders grew to 184 Mn (up 39% YoY). Our Q4FY24 profitability was impacted due to grant of ESOPs for acquiring and retaining top talent. We are in the growth phase of our business, and we continue to see a good momentum in our core metrics.?

Meanwhile, the board approved issuance of secured or unsecured redeemable non‐convertible debentures, in one or more tranches on an annual basis through private placement basis, upto a limit of Rs 250 crore, subject to the approval of the members.

5Paisa Capital is engaged in stock broking and trading and so there were no activities in the nature of research and development involved in the business.

However, revenue from operations jumped 23.44% year on year (YoY) to Rs 4,018.5 crore in the quarter ended 31 March 2024.

The realtor reported pre-sales of Rs 4,230 crore in Q4 FY24, recording a growth of 40% on a YoY basis. Collections grew by 20% YoY at Rs 3,510 crore during the quarter.

The company delivered robust pre-sales and collections on the back of strong operating cash flow generation coupled with the recently concluded QIP, net debt further reduced sharply to Rs 3,010 crore (0.17x of equity) for the firm ? well below its guided ceiling of 0.5x of equity, said the company.

Profit before tax in Q4 FY24 was at Rs 878.5 crore, up 37.65% from Rs 638.2 crore posted in Q4 FY23.

Total expenses spiked 21.83% YoY to Rs 3,204.7 crore during the quarter. Cost of projects stood at Rs 2,522.1 crore (up 21.76% YoY) and employee benefits expense came in at Rs 119.6 (up 15.56% YoY).

Adjusted EBITDA jumped 36.73% to Rs 1,340 crore in the March quarter as against Rs 980 crore recorded in Q4 FY23. Adjusted EBITDA margin improved to 33% in Q4 FY24 as compared to 30% registered in the same period a year ago.

For FY24, the real estate developer reported a consolidated net profit of Rs 1549.1 crore, steeply higher than Rs 486.7 crore reported in FY23. Revenue from operations grew 8.93% YoY to Rs 10316.1 crore in FY24.

Abhishek Lodha, MD & CEO, Macrotech Developers, said, ?Driven by the strength of our brand, we delivered pre-sales of Rs 145 billion for FY24, thus meeting our guidance of delivering consistent and predictable 20% growth. Our Q4FY24 pre-sales stood at Rs 42.3 billion showing a strong 40% YoY growth.

We have achieved our guidance of reducing our net debt well below 0.5x of equity. Robust operating cash flows and our capital raise led to net debt coming down by over Rs 40 billion during the year to Rs ~30 billion which is less than 0.2x of equity. The sharp reduction in net debt has happened along-side addition of new projects of over Rs 200 billion during the year. Our enhanced financial strength will provide us an opportunity to accelerate margin as well as top line growth as the capital is invested over the next 6-12 months.

Meanwhile, the company?s board recommended a final dividend of Rs 2.25 for the financial year ended 31 March 2024.

Macrotech Developers (Lodha Group) is among the largest real estate developer in India that delivers with scale since 1980s. Core business of Lodha Group is residential real estate development with a focus on affordable and mid-income housing.

Of the total sum payable, an amount of Rs 635 crore would be paid upfront on closing and the balance of Rs 144 crore would be deferred, payable at the end of FY25 on achievement of set performance targets.

PureSoftware with a global presence and headquarters in Noida is a fast-growing digital engineering & transformation services and solutions provider with deep domain expertise. PureSoftware partners with global enterprises across focused verticals which include banking & financial services and insurance (BFSI), healthcare & life sciences, retail & logistics, and gaming & entertainment. The company also has an award-winning banking-as-a-service platform ?Arttha?. PureSoftware reported revenues of $43 million (approximately Rs 351 crore) for fiscal 2024.

Through this acquisition, Happiest Minds strengthens its domain capabilities in banking, financial services, insurance (BFSI) and healthcare and life sciences verticals. In addition to augmenting its presence in USA, UK and India, Happiest Minds will also get a near-shore presence in Mexico and offices in Singapore, Malaysia, and Africa.

Joseph Anantharaju, executive vice chairman, Happiest Minds, said: ?PureSoftware brings with it strong capabilities in banking, insurance and healthcare domains; allowing us to add value and upsell to our customers.

We are excited by the potential to cross-sell analytics, GenAI, automation, infrastructure management and cyber security services to PureSoftware customers and drive accelerated growth for Happiest Minds.?

Happiest Minds Technologies, an IT solutions company, enables digital transformation for enterprises and technology providers by delivering seamless customer experiences, business efficiency and actionable insights.

The IT company's consolidated net profit rose 2% to Rs 59.62 crore in Q3 FY24 as against Rs 58.46 crore recorded in Q2 FY24.

The scrip rose 0.51% to currently trade at Rs 822.70 on the BSE.